3644 results for «2805»
3644 results
How should I treat this vulnerable plaque?
21 May 2025 – From EuroPCR 2025
Learn to identify and manage vulnerable plaque using intracoronary imaging. This session covers detection techniques, clinical implications, current evidence for treatment, and case-based insights to improve patient outcomes through targeted intervention.
Imaging coronary artery disease – New frontiers
21 May 2025 – From EuroPCR 2025
Delve into new frontiers in imaging coronary artery disease, shifting focus from ischemia to plaque characteristics for revascularisation decisions. This session highlights the pivotal role of intracoronary imaging in understanding complex vessel anatomy and planning treatment, illustrated through detailed case studies showcasing unusual anatomies requiring tailored...
Valve-in-valve TAVI
21 May 2025 – From EuroPCR 2025
Explore valve-in-valve TAVI strategies for patients with degenerated surgical valves, focusing on small aortic annuli. This session covers the impact of valve design and implant techniques, valve fracturing methods, procedural outcomes of repeat TAVI, and mid-to-long-term results from the ACCURATE NEO 2 study.
TAVI in challenging cases: pushing the limits
21 May 2025 – From EuroPCR 2025
Navigate challenging TAVI cases with this focused session emphasizing valve-in-valve procedures in complex anatomical scenarios. Learn strategies for managing TAVI in patients with multivessel disease and impaired ventricular function, and optimize procedural planning using advanced imaging, access methods, and device selection through detailed case presentations and...
PCR's Got Talent - Round 2 - Session 1
21 May 2025 – From EuroPCR 2025
PCR's Got Talent Round 2 Session 1 showcases emerging talents and innovations in interventional cardiology, highlighting promising advancements and expert insights shaping the future of cardiovascular interventions.
Novel tools and strategies in chronic heart failure
21 May 2025 – From EuroPCR 2025
Discover novel tools and therapeutic strategies in chronic heart failure management. This session presents early clinical experiences with innovative devices such as a chronically-adjustable pressure sensing interatrial shunt, synchronized diaphragmatic stimulation, high-flow pLVADs for cardiogenic shock, and renal artery denervation. Additionally, it reviews the impact of...
Hostile access for TAVI procedure
21 May 2025 – From EuroPCR 2025
This session addresses the challenges of hostile vascular access in TAVI procedures. Learn to identify difficult access sites through pre-operative imaging, explore alternative approaches such as axillary access, techniques to overcome iliac access difficulties, and management of peri- and post-operative complications by vascular surgeons.
Multi-modality assessment of coronary disease
21 May 2025 – From EuroPCR 2025
This session offers comprehensive multi-modality assessment of coronary disease, integrating advanced imaging and functional testing. Topics include diagnostic yield of OCT and cardiac MRI for MINOCA, transitioning coronary plaque vulnerability assessment from invasive to non-invasive methods, relationships between QFR and IVUS post-PCI in complex lesions, combined...
TEER for challenging anatomy: from myth to reality
21 May 2025 – From EuroPCR 2025
Explore advanced TEER techniques for challenging anatomies. This session covers indications, periprocedural steps, state-of-the-art procedural methods, and management of failed surgical tricuspid annuloplasty, with case discussions highlighting practical learnings for complex mitral and tricuspid interventions.
New tools for left main treatment
21 May 2025 – From EuroPCR 2025
Examine new tools and strategies tailored for left main coronary artery treatment. This session covers real-world data on intracoronary imaging guidance, post-PCI FFR assessment following provisional T stenting, safety and efficacy of intravascular lithotripsy for calcified left main disease, drug-coated balloon (DCB) treatments for true bifurcation...
Treatment and prognostic stratification of ACS patients with cardiogenic shock
21 May 2025 – From EuroPCR 2025
This session focuses on treatment and prognostic stratification in ACS patients complicated by cardiogenic shock. Topics include mechanical CPR device performance, SCAI shock grade dynamics, hemorrhagic event predictors, ECMO-related strategies, and evaluation of BCIS conveyance algorithms for out-of-hospital cardiac arrest.
TAVI: contemporary practice
21 May 2025 – From EuroPCR 2025
Stay updated on contemporary TAVI practices with insights from the 2024 European TAVI PATHWAY Registry. This session addresses comprehensive risk stratification in moderate aortic stenosis, safety and efficacy of repeat TAVI procedures, comparative outcomes of explant versus redo-TAVI after valve failure, and long-term neurological outcomes following...
Intracoronary imaging for complex PCI: a must!
21 May 2025 – From EuroPCR 2025
Recognize the indispensable role of intracoronary imaging in managing complex PCI cases. This session explores the evolution of multivessel NSTEMI treatment using DES, BRS, DCB, and imaging, challenges with recurrent in-stent restenosis across multiple stent layers, innovative imaging solutions for complex lesions, and diagnostic approaches to...
Management of stent-related complications
21 May 2025 – From EuroPCR 2025
This session addresses the management of stent-related complications through a series of dramatic clinical cases. Learn methodical approaches to routine and crisis scenarios including primary PCI complications, failure to stent, and unexpected challenges encountered during interventions, highlighting practical bailout techniques and decision-making frameworks.
TAV-in-TAV complications
21 May 2025 – From EuroPCR 2025
Focus on the complexities and challenges of TAV-in-TAV procedures in this session. Topics include planning valve-in-valve TAVI for aortic bioprosthetic valve regurgitation, managing anatomical challenges such as left ventricular outflow tract calcium and large annulus, and addressing severe bicuspid valve stenosis with impaired ventricular function. The...
Iatrogenic causes for shock treated with LV support
21 May 2025 – From EuroPCR 2025
Explore the management of iatrogenic causes of cardiogenic shock requiring left ventricular support. This session presents complex cases including shock following Bentall procedures, complications during anesthesia induction in bypass surgery, and strategic approaches to prevent and manage these critical scenarios using LV support devices.
TAVI for aortic regurgitation: off-label use
21 May 2025 – From EuroPCR 2025
Explore the complexities and off-label challenges of transcatheter aortic valve implantation (TAVI) in patients with severe pure aortic regurgitation. This session highlights the bold strategies, complication management, and innovative use of the Octacor valve in this demanding clinical scenario, providing valuable insights into navigating a difficult...
Treatment dilemmas in STEMI patients with multivessel disease
21 May 2025 – From EuroPCR 2025
Address treatment dilemmas in STEMI patients with multivessel disease through this session focused on imaging and physiology-guided revascularisation strategies. Learn optimal approaches for cases with CABG indications, and timing considerations for non-culprit vessel revascularisation during hospital admission or later stages, supported by illustrative clinical cases.
Large thrombus burden: contemporary solutions
21 May 2025 – From EuroPCR 2025
This session presents contemporary strategies for managing large thrombus burden in STEMI patients. Learn from expert cases demonstrating multiple effective approaches including modified manual thrombus aspiration guided by intravascular ultrasound (IVUS) and streamlined primary PCI techniques, essential for optimizing outcomes in complex thrombotic scenarios.
Stent technologies, last evidence in coronary interventions
21 May 2025 – From EuroPCR 2025
Update your knowledge on the latest stent technologies and clinical evidence in coronary interventions. This session reviews long-term outcomes of resorbable magnesium scaffolds, seven-year data from the COMPARE-ABSORB trial, bioadaptor versus stent comparisons, dual therapy sirolimus-eluting versus biolimus-eluting stents, and randomized trials on direct stenting versus...
